EMILY BERTSCH: Open Payments
NPI 1356869267 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$819 in 43 payments from 23 companies in 2025. Trend: 2023 $137 · 2024 $562 · 2025 $819
Food & beverage: $819
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 6 | $117 |
| Novartis Pharmaceuticals Corporation | 4 | $82 |
| Genentech USA, Inc. | 4 | $79 |
| JAZZ PHARMACEUTICALS INC. | 3 | $70 |
| Daiichi Sankyo Inc. | 3 | $56 |
| Merck Sharp & Dohme LLC | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Celgene Corporation | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| ARRAY BIOPHARMA INC | 2 | $31 |
Products named: ZEPZELCA, MONJUVI, KEYTRUDA, JAKAFI, Polivy, DATROWAY, Fabhalta, Enhertu.
Industry payments across FL — which companies pay providers there.
